Marriage Counselors in Hopkins, MN Accepting Medicare

9 Marriage Counselors found. Showing 1 - 9

Tessa Gittleman, LMFT Marriage & Family Therapist Medicare: Not Enrolled in Medicare Practice Location: 904 Mainstreet Ste 200, Hopkins, MN 55343 Phone: 866-522-2472    Fax: 763-717-8049

Samantha Iverson, LMFT Marriage & Family Therapist Medicare: Not Enrolled in Medicare Practice Location: 1605 Mainstreet Ste 2a, Hopkins, MN 55343 Phone: 612-756-8353

Jennifer Urena-taveras, LMFT Marriage & Family Therapist Medicare: Not Enrolled in Medicare Practice Location: 1001 Highway 7, Hopkins, MN 55305 Phone: 952-938-7040    Fax: 952-938-4708

Ms. Rebecca Hea Rin Erickson, MA, LAMFT Marriage & Family Therapist Medicare: Not Enrolled in Medicare Practice Location: 1025 2nd St Ne Apt 203, Hopkins, MN 55343 Phone: 612-248-0700

Deanne T Shaw, LMFT Marriage & Family Therapist Medicare: Medicare Enrolled Practice Location: 1001 Highway 7, Suite 305, Hopkins, MN 55305 Phone: 952-938-7040    Fax: 952-938-4708

Mrs. Kelly Jean Blondell, LMFT Marriage & Family Therapist Medicare: Not Enrolled in Medicare Practice Location: 750 2nd St Ne Ste 218, Hopkins, MN 55343 Phone: 612-245-8661

Stephanie Martin, MA Marriage & Family Therapist Medicare: Not Enrolled in Medicare Practice Location: 314 17th Ave N, Hopkins, MN 55343 Phone: 612-599-4018

Ms. Lisa Weir, M.A., LMFT Marriage & Family Therapist Medicare: Not Enrolled in Medicare Practice Location: 904 Mainstreet Ste 200, Hopkins, MN 55343 Phone: 952-562-4116

Ms. Nicole Anderson Arthur, MA, LMFT Marriage & Family Therapist Medicare: Not Enrolled in Medicare Practice Location: 1001 Highway 7 Ste 305, Hopkins, MN 55305 Phone: 952-938-7040

News Archive

Bayhill's BHT-3034 receives FDA IND clearance for treatment of myasthenia gravis

Bayhill Therapeutics Inc, a clinical-stage biopharmaceutical company utilizing its proprietary BHT-DNA™ platform to develop novel and targeted autoimmune and immune-mediated disease treatments, today announced the successful clearance of an IND with the US FDA for BHT-3034, a disease-modifying DNA plasmid vaccine immunotherapy for patients with the autoimmune neuromuscular junction disease myasthenia gravis.

First Edition: October 29, 2010

Today's headlines include news about the effort to repeal the health law and Republican and Democrat strategies related to the next Congress.

UIC researchers to study the impact of chronic eye disease among Latinos

With $9.7 million in funding from the National Eye Institute, researchers at the University of Illinois at Chicago will study the impact of chronic eye disease among Latinos.

Santarus, Pharming submit RHUCIN BLA to FDA for treatment of HAE attacks

Specialty biopharmaceutical company Santarus, Inc. and biotech company Pharming Group NV today announced the submission of a Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) to obtain marketing approval for RHUCIN® (recombinant human C1 inhibitor) for the treatment of acute angioedema attacks in patients with Hereditary Angioedema (HAE).

Read more Medical News

› Verified 2 days ago